PREreviews of Insulin resistance alters cortical inhibitory neurons and microglia to exacerbate Alzheimer’s knock-in mouse phenotypes

3 PREreviews

1. PREreview by Fisher Cherry et al. of HHMI Transparent and Accountable Peer Review Training Program

   Authored by Fisher Cherry and 1 other author of HHMI Transparent and Accountable Peer Review Training Program

   Summary

               A growing body of work suggests that metabolic dysfunction, such as diabetes mellitus, can aggravate the cognitive decline of patients with Alzheimer’s disease (AD); however, the molecular basis for the overlap in metabolic dysfunction in both Alzheimer’s and diabetes mellitus…

   Read the PREreview by Fisher Cherry et al. of HHMI Transparent and Accountable Peer Review Training Program

2. PREreview by Yan Li et al. of HHMI Transparent and Accountable Peer Review Training Program

   Authored by Yan Li and 1 other author of HHMI Transparent and Accountable Peer Review Training Program

   In this manuscript, Nicholson et al. investigated whether hyperglycemia caused by decreased insulin vs insulin resistance drives AD pathology. The interest in addressing this question stems from the observation that type 2 diabetes and people with metabolic syndrome (MetS) show early onset of…

   Read the PREreview by Yan Li et al. of HHMI Transparent and Accountable Peer Review Training Program

3. PREreview by Xue Deng of HHMI Transparent and Accountable Peer Review Training Program

   Authored by Xue Deng of HHMI Transparent and Accountable Peer Review Training Program

   In this manuscript, Nicholson et al., investigate how systemic metabolic dysfunction alters brain function in Alzheimer’s disease (AD). Building on prior evidence that both hyperglycemia and insulin signaling deficits contribute to AD risk, a key question addressed by this study is whether it is…

   Read the PREreview by Xue Deng of HHMI Transparent and Accountable Peer Review Training Program